ATC code N02

ATC code N02 Analgesics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.^[1]^[2]^[3] Subgroup N02 is part of the anatomical group N Nervous system.^[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QN02.^[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

N02A Opioids

N02AA Natural opium alkaloids

N02AA01 Morphine

N02AA02 Opium

N02AA03 Hydromorphone

N02AA04 Nicomorphine

N02AA05 Oxycodone

N02AA08 Dihydrocodeine

N02AA10 Papaveretum

N02AA11 Oxymorphone

N02AA51 Morphine, combinations

N02AA53 Hydromorphone and naloxone

N02AA55 Oxycodone and naloxone

N02AA56 Oxycodone and naltrexone

N02AA58 Dihydrocodeine, combinations

N02AA59 Codeine, combinations excluding psycholeptics

N02AA79 Codeine, combinations with psycholeptics

N02AB Phenylpiperidine derivatives

N02AB01 Ketobemidone

N02AB02 Pethidine

N02AB03 Fentanyl

N02AB52 Pethidine, combinations excluding psycholeptics

QN02AB53 Fentanyl, combinations excluding psycholeptics

N02AB72 Pethidine, combinations with psycholeptics

QN02AB73 Fentanyl, combinations with psycholeptics

N02AC Diphenylpropylamine derivatives

N02AC01 Dextromoramide

N02AC03 Piritramide

N02AC04 Dextropropoxyphene

N02AC05 Bezitramide

N02AC52 Methadone, combinations excluding psycholeptics

N02AC54 Dextropropoxyphene, combinations excluding psycholeptics

N02AC74 Dextropropoxyphene, combinations with psycholeptics

QN02AC90 Methadone

N02AD Benzomorphan derivatives

N02AD01 Pentazocine

N02AD02 Phenazocine

N02AD51 Pentazocine and naloxone

N02AE Oripavine derivatives

N02AE01 Buprenorphine

QN02AE90 Etorphine

QN02AE99 Oripavine derivatives, combinations

N02AJ03 Dihydrocodeine and other non-opioid analgesics

N02AJ06 Codeine and paracetamol

N02AJ07 Codeine and acetylsalicylic acid

N02AJ08 Codeine and ibuprofen

N02AJ09 Codeine and other non-opioid analgesics

N02AJ13 Tramadol and paracetamol

N02AJ14 Tramadol and dexketoprofen

N02AJ15 Tramadol and other non-opioid analgesics

N02AJ16 Tramadol and celecoxib

N02AJ17 Oxycodone and paracetamol

N02AJ18 Oxycodone and acetylsalicylic acid

N02AJ19 Oxycodone and ibuprofen

N02AJ22 Hydrocodone and paracetamol

N02AJ23 Hydrocodone and ibuprofen

N02AX Other opioids

N02AX01 Tilidine

N02AX02 Tramadol

N02AX03 Dezocine

N02AX05 Meptazinol

N02AX06 Tapentadol

N02AX07 Oliceridine

N02AX51 Tilidine and naloxone

N02B Other analgesics and antipyretics

N02BA Salicylic acid and derivatives

N02BA01 Acetylsalicylic acid

N02BA02 Aloxiprin

N02BA03 Choline salicylate

N02BA04 Sodium salicylate

N02BA05 Salicylamide

N02BA06 Salsalate

N02BA07 Ethenzamide

N02BA08 Morpholine salicylate

N02BA09 Dipyrocetyl

N02BA10 Benorilate

N02BA11 Diflunisal

N02BA12 Potassium salicylate

N02BA14 Guacetisal

N02BA15 Carbasalate calcium

N02BA16 Imidazole salicylate

N02BA51 Acetylsalicylic acid, combinations excluding psycholeptics

N02BA55 Salicylamide, combinations excluding psycholeptics

N02BA57 Ethenzamide, combinations excluding psycholeptics

N02BA59 Dipyrocetyl, combinations excluding psycholeptics

N02BA65 Carbasalate calcium combinations excluding psycholeptics

N02BA67 Magnesium salicylate, combinations excluding psycholeptics

N02BA71 Acetylsalicylic acid, combinations with psycholeptics

N02BA75 Salicylamide, combinations with psycholeptics

N02BA77 Ethenzamide, combinations with psycholeptics

N02BA79 Dipyrocetyl, combinations with psycholeptics

N02BB Pyrazolones

N02BB01 Phenazone

N02BB02 Metamizole

N02BB03 Aminophenazone

N02BB04 Propyphenazone

N02BB05 Nifenazone

N02BB51 Phenazone, combinations excluding psycholeptics

N02BB52 Metamizole sodium, combinations excluding psycholeptics

N02BB53 Aminophenazone, combinations excluding psycholeptics

N02BB54 Propyphenazone, combinations excluding psycholeptics

N02BB71 Phenazone, combinations with psycholeptics

N02BB72 Metamizole sodium, combinations with psycholeptics

N02BB73 Aminophenazone, combinations with psycholeptics

N02BB74 Propyphenazone, combinations with psycholeptics

N02BE Anilides

N02BE01 Paracetamol

N02BE03 Phenacetin

N02BE04 Bucetin

N02BE05 Propacetamol

N02BE51 Paracetamol, combinations excluding psycholeptics

N02BE53 Phenacetin, combinations excluding psycholeptics

N02BE54 Bucetin, combinations excluding psycholeptics

N02BE71 Paracetamol, combinations with psycholeptics

N02BE73 Phenacetin, combinations with psycholeptics

N02BE74 Bucetin, combinations with psycholeptics

N02BF Gabapentinoids

N02BF01 Gabapentin

N02BF02 Pregabalin

N02BF03 Mirogabalin

N02BG Other analgesics and antipyretics

N02BG02 Rimazolium

N02BG03 Glafenine

N02BG04 Floctafenine

N02BG05 Viminol

N02BG06 Nefopam

N02BG07 Flupirtine

N02BG08 Ziconotide

N02BG09 Methoxyflurane

N02BG10 Cannabinoids (includes nabiximols)

N02BG12 Tanezumab

QN02BG90 Frunevetmab

QN02BG91 Bedinvetmab

N02C Antimigraine preparations

N02CA Ergot alkaloids

N02CA01 Dihydroergotamine

N02CA02 Ergotamine

N02CA04 Methysergide

N02CA07 Lisuride

N02CA51 Dihydroergotamine, combinations

N02CA52 Ergotamine, combinations excluding psycholeptics

N02CA72 Ergotamine, combinations with psycholeptics

N02CB Corticosteroid derivatives

N02CB01 Flumedroxone

N02CC Selective serotonin (5-HT₁) agonists

N02CC01 Sumatriptan

N02CC02 Naratriptan

N02CC03 Zolmitriptan

N02CC04 Rizatriptan

N02CC05 Almotriptan

N02CC06 Eletriptan

N02CC07 Frovatriptan

N02CC08 Lasmiditan

N02CC51 Sumatriptan and naproxen

N02CD Calcitonin gene-related peptide (CGRP) antagonists

N02CD01 Erenumab

N02CD02 Galcanezumab

N02CD03 Fremanezumab

N02CD04 Ubrogepant

N02CD05 Eptinezumab

N02CD06 Rimegepant

N02CD07 Atogepant

N02CX Other antimigraine preparations

N02CX01 Pizotifen

N02CX02 Clonidine

N02CX03 Iprazochrome

N02CX05 Dimetotiazine

N02CX06 Oxetorone

References

^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
^ "ATC/DDD Index 2022: code N02". WHO Collaborating Centre for Drug Statistics Methodology.
^ "ATCvet Index 2022: code QN02". WHO Collaborating Centre for Drug Statistics Methodology.

[1] "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.

[2] World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.

[3] "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.

[4] "ATC/DDD Index 2022: code N02". WHO Collaborating Centre for Drug Statistics Methodology.

[5] "ATCvet Index 2022: code QN02". WHO Collaborating Centre for Drug Statistics Methodology.

[1]

[2]

[3]

[4]

[5]

ATC code N: Nervous system
N01 Anesthetics N02 Analgesics N03 Antiepileptics N04 Anti-parkinson drugs N05 Psycholeptics N06 Psychoanaleptics N07 Other nervous system drugs
ATCvet only
QN51 Products for animal euthanasia
Other ATC codes
A B C D G H QI J L M N P R S V